BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16459060)

  • 1. Linking molecular motors to Alzheimer's disease.
    Stokin GB; Goldstein LS
    J Physiol Paris; 2006; 99(2-3):193-200. PubMed ID: 16459060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal transport and Alzheimer's disease.
    Stokin GB; Goldstein LS
    Annu Rev Biochem; 2006; 75():607-27. PubMed ID: 16756504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: an intracellular movement disorder?
    Zhu X; Moreira PI; Smith MA; Perry G
    Trends Mol Med; 2005 Sep; 11(9):391-3. PubMed ID: 16087404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
    Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
    Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new hypothesis for early pathogenesis in Alzheimer's disease: impaired axonal transport mechanism].
    Zhu YB; Lu PH; Sheng ZH
    Sheng Li Ke Xue Jin Zhan; 2008 Jan; 39(1):5-9. PubMed ID: 18357680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of amyloid plaque pathogenesis.
    Fiala JC
    Acta Neuropathol; 2007 Dec; 114(6):551-71. PubMed ID: 17805553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.
    Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH
    Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of axonal transport in Alzheimer's disease.
    Vicario-Orri E; Opazo CM; Muñoz FJ
    J Alzheimers Dis; 2015; 43(4):1097-113. PubMed ID: 25147115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The molecular mechanisms of Alzheimer's disease: approach from the amyloid precursor protein].
    Nakaya T; Toshiharu S
    Tanpakushitsu Kakusan Koso; 2002 Sep; 47(11):1405-14. PubMed ID: 12229208
    [No Abstract]   [Full Text] [Related]  

  • 16. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
    Ledesma MD; Dotti CG
    FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
    Marcello E; Epis R; Di Luca M
    Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.